PROFILE OF URINARY TRACT INFECTIONS PATHOGENS AND THEIR ANTIMICROBIAL RESISTANCE PATTERNS DURING THREE-YEAR PERIOD (2009 – 2011) IN THE CLINICAL CENTER KRAGUJEVAC
Abstract
Urinary tract infections are common bacterial diseases and also a frequent reason for prescribing antibiotics. Knowledge about the type of pathogens and their resistance patterns may help the clinician to choose the correct treatment. In this study, the prevalence and the resistance pattern of the main bacteria responsible for urinary tract infections оf hospitalized patients in Clinical centar Kragujevac was evaluated throughout a tree-year period.
Cross-sectional study in the hospital settings was conducted and urine samples were collected from 662 patients with urinary tract infections and tested using standard procedures. The disk-diffusion method on Mueller-Hinton agar according to Clinical and Laboratory Standards Institute guidelines (CLSI) was performed for assessment of antimicrobial susceptibility.
The most frequently isolated pathogen were Klebsiella spp. (219 isolates, i.e. 33,1%), Proteus mirabilis (107 isolates, i.e. 16,2%), Enterobacter (86 isolates, i.e. 13%), Escherichia coli (82 isolates, i.e. 12,4%), Pseudomonas aeruginosa (70 isolates, i.e. 10,6%), Enterococcus spp (39 isolates, i.e. 5,9% ) and Proteus vulgaris (38 isolates, i.e. 5,7%). Group of patients older than 65 years was the largest one 426 (64,4%). Gram negative bacteria showed the highest degree of resistance (92.3% - 100%) to penicillins (ampicillin, amoxicillin, amoxicillin + clavulanic acid) and third-generation cephalosporins (cefotaxime, ceftriaxone and ceftazidime) (88.3% - 98, 4%), while Gram positive Enterococcus spp showed the highest degree of resistance to aminoglycosides (gentamicin and amikacin) (96.8% - 100%) and fluoroquinolone ciprofliksacin (100%). The lowest resistance rate of the studied Gram negative pathogens was to carbapenems (imipenem and meropenem) and piperacillin / tazobactam (6.9% - 35.5%), while the lowest level of resistance of gram positive Enterococcus spp was found to glycopeptide antibiotics (vancomycin and teicoplanin) (3.0% - 3.3%).
When choosing antibiotics, the pharmacokinetics and pharmacodynamics, renal and liver function, adverse reactions with other drugs, as well as the results of susceptibility testing should be taken into consideration. According to our data, empiric treatment for Klebsiella spp, Proteus mirabilis, Enterobacter, Escherichia coli, Pseudomonas aeruginosa and Proteus vulgaris should include carbapenems or piperacillin / tazobactam, and when it comes to Enterococcus spp, glycopeptide antibiotics are appropriate choice.
References
Bergman M, Nyberg S, Huovinen P, Paakkari P, Hakanen A, -Finnish Study Group for Antimicrobial Resistance . Association between Antimicrobial Consumption and Resistance in Escherichia coli. Antimicrobial Agents And Chemotherapy 2009 53(3): 912-7.
Ronald AR, Nicolle LE, Stamm E, Krieger J, Warren J, Schaeffer A, Naber KG,Hooton TM, Johnson J, Chambers S, Andriole V. Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents 2001; 17(4): 343-8.
Nicoletti J, Kuster SP, Sulser T, Zbinden R, Ruef C, Ledergerber B, Weber R. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland. Swiss Med Wkly 2010; 140: 13059.
Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS Project. J Antimicrob Chemother 2003; 51(1): 69-76.
Giamarellou H. Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Int J Antimicrob Agents 2010; 36S: 50-4.
Livermore DM, Pearson A. Antibiotic resistance: location, location, location. Clin Мicrobiol Infect 2007; 13 (Suppl 2): 7-16.
Magliano E, Grazioli V, Deflorio L, Leuci AI, Mattina R, Romano P, Cocuzza CE. Gender and age-dependent etiology of community-acquired urinary tract infections. ScientificWorldJournal. 2012 ;2012: 349597.
Potic M, Ignjatovic I. Catheter-associated and nosocomial urinary tract infections: antibiotic resistance and influence on commonly used antimicrobial therapy. Int Urol Nephrol 2009; 41(3): 461-464.
CLSI.. Performance standards for antimicrobial susceptibility testing. 2011. Twenty-first informational supplement.
Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO•SENS study revisited. Int J Antimicrob Agents 2012; 39(1): 45-51.
Farrell DJ, Morrissey I, de Rubeis D, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003; 46(2): 94-100.
Dada-Adegbola HO, Muili KA. Antibiotic susceptibility pattern of urinary tract pathogens in Ibadan, Nigeria. Afr J Med Med Sci 2010; 39(3):173-9.
Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis 2013; 13: 19.
Tabibian JH, Gornbein J, Heidari A, Dien SL, Lau VH, Chahal P, Churchill BM, Haake DA. Uropathogens and host characteristics. J Clin Microbiol 2008; 46(12): 3980-6.
Gasink L, Edelstein P, Lautenbach E, Synnestvedt M, Fishman N. Risk Factors and Clinical Impact of Klebsiella pneumonia Carbapenemase-Producing K. pneumonia. Infect Control Hosp Epidemiol 2009; 30(12): 1180-5.
Falagas M, Rafailidis P, Kofteridis D. Risk factors of carbapenem-resistant Klebsiella pneumonia infections: a matched case–control study. J Antimicrob Chemother 2007; 60: 1124-30.
Subramanian P, Shanmugam N, Sivaraman U, Kumar S, Selvaraj S. Antiobiotic resistance pattern of biofilm-forming uropathogens isolated from catheterized patients in Pondicherry, India. Australas Med J 2012; 5(7): 344-8.
Ghadiri H, Vaez H, Khosravi S, Soleymani E. The antibiotic resistance profiles of bacterial strains isolated from patients with hospital-acquired bloodstream and urinary tract infections. Crit Care Res Pract 2012; 2012: 890797.
Karlowsky JA, Lagacé-Wiens PR, Simner PJ, DeCorby MR, Adam HJ, Walkty A, Hoban DJ, Zhanel GG. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrob Agents Chemother 2011; 55(7): 3169-75.
Feglo KP, Gbedema YS, Armar QNS, Adu-Sarkodie Y, Opoku-Okrah C. Occurrence, species distribution and antibiotic resistance of Proteus isolates: A case study at the Komfo Anokye Teaching Hospital (KATH) in Ghana. Int J Pharm Sci Res 2010; 1(9): 347-52.
Cantón R, Loza E, Aznar J, Calvo J, Cercenado E, Cisterna R, Romo FG, Hontangas JL, Calvo CR, Barrenechea AI, Tubau F, Weber I, Yuste P, Cavanillas R; SMART-Spain Working Group. Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010). Rev Esp Quimioter 2011; 24(4): 223-32.
Tumbarello M, Trecarichi EM, Fiori B, Losito AR, Tiziana D, Campana L, Spanu T. Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes. Antimicrob Agents Chemother 2012; 56(6): 3224-31.
Sreeja S, Babu SPR, Prathab AG. The Prevalence and the Characterization of the Enterococcus Species from Various Clinical Samples in a Tertiary Care Hospital. J Clin Diagn Res 2012; 6(9): 1486-8.
Salem-Bekhit MM, Moussa IMI, Muharram MM, Alanazy FK, Hefni HM. Prevalence and antimicrobial resistance pattern of multidrug-resistant enterococci isolated from clinical specimens. Indian J Med Microbiol 2012; 30(1): 44-51.
Zilberberg MD, Chen J, Mody SH, Ramsey AM, Shorr AF. Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm Med 2010; 10: 45.
Tan TY, Hsu LY, Koh TH, Ng LSY, Tee NWS, Krishnan P, Jureen R. Antibiotic resistance in gram-negative bacilli: a Singapore perspective. Ann Acad Med Singap 2008; 37(10): 819-25.
Thierfelder C, Keller PM, Kocher C. Vancomycin-resistant Enterococcus. Swiss Med Wkly 2012; 142: w13540.
Johnson PDR, Ballard SA, Grabsch EA, Stinear TP, Seemann T, Young HL, Howden BP. A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203. J Infect Dis 2010; 202(8): 1278-86.
Jankovic S. Rational Use Of Antibiotics In Clinical Practice. Racionalna terapija 2009; 1(1): 1-6.